Search - tctmd.com

Displaying 101 - 120 of 291

Sort: Relevancy | Date

Presentation TVT 2017

Endogenous Tissue Restoration: Preclinical Investigation With Bioresorbable, Pulmonary, and Aortic Valves

Presenter: Patrick W. Serruys

June 16, 2017

Presentation TVT 2017

The Self-Expanding Single-Operator CENTERA TAVR System

Presenter: Didier Tchetche

June 16, 2017

Presentation TVT 2017

The Future Role of Tissue Engineered Aortic Valves for TAVR (and SAVR)

Presenter: A. Pieter Kappetein

June 16, 2017

Presentation TVT 2017

The Venus A-Valve and Venibri TAVR Systems Better for Bicuspids and Dry Leaflet Technology

Presenter: Horst Sievert

June 16, 2017

Presentation TVT 2017

The Anatomically Correct JenaValve TAVR System Pure AR Treatment

Presenter: Hendrik Treede

June 16, 2017

Presentation TVT 2017

Threatened Left Main Avoid, Pre-Emptive Planning, or React as Needed

Presenter: John K. Forrest, James M. McCabe, Jean-Michel Paradis

June 16, 2017

Presentation TVT 2017

Inadequate Femoral Access All Roads Lead to Rome

Presenter: John K. Forrest, James M. McCabe, Adam B. Greenbaum

June 16, 2017

Presentation TVT 2017

Sizing in the Gray Zone

Presenter: John K. Forrest, James M. McCabe, Christopher U. Meduri

June 16, 2017

Presentation TVT 2017

Hard as Rock Calcium Annulus and LOVT Scenarios

Presenter: John K. Forrest, James M. McCabe, Kendra J. Grubb

June 16, 2017

Presentation TVT 2017

Extreme East-West (Horizontal) Aorta

Presenter: John K. Forrest, James M. McCabe, Saif Anwaruddin

June 16, 2017

Presentation TVT 2017

How Many TAVR Systems Are Needed in a Busy TAVR Program?

Presenter: Ganesh Manoharan, Hendrik Treede, Axel Linke

June 16, 2017

Presentation TVT 2017

Classification of Aortic Stenosis Based Upon the Extent of Cardiac Damage A Novel Concept

Presenter: Robert O. Bonow, Martin B. Leon, Philippe Généreux

June 15, 2017

News Features

Valve, Heal Thyself: Pioneers Seek Tissue-Engineered Fix for Faulty, Failing Cardiac Parts

Caitlin E. Cox

June 14, 2017

Presentation EuroPCR 2017

A Prospective, Randomised Investigation of a Novel Transcatheter Aortic Valve Implantation System: The REPRISE III Trial

Presenter: Ted E. Feldman

May 16, 2017

News Conference News EuroPCR 2017

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

Shelley Wood

May 12, 2017

News Daily News

Permanent Pacemakers After TAVR: Model Helps Predict Individual Patient Risk With Sapien 3

L.A. McKeown

April 12, 2017

News Conference News ACC 2017

Live From Washington: ACC 2017, Day One

Shelley Wood

March 17, 2017

News Conference News ACC 2017

SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients

Todd Neale

March 17, 2017

Presentation SIF 2017

Novel Applications: Utilizing Impella to Support TAVR Patients

Presenter: Robert D. Riley

March 11, 2017

News Daily News

Edward ‘Ted’ Diethrich, Founder of the Arizona Heart Institute, Dies at 81

L.A. McKeown

March 01, 2017

Advertisement

Endogenous Tissue Restoration: Preclinical Investigation With Bioresorbable, Pulmonary, and Aortic Valves

The Self-Expanding Single-Operator CENTERA TAVR System

The Future Role of Tissue Engineered Aortic Valves for TAVR (and SAVR)

The Venus A-Valve and Venibri TAVR Systems Better for Bicuspids and Dry Leaflet Technology

The Anatomically Correct JenaValve TAVR System Pure AR Treatment

Threatened Left Main Avoid, Pre-Emptive Planning, or React as Needed

Inadequate Femoral Access All Roads Lead to Rome

Sizing in the Gray Zone

Hard as Rock Calcium Annulus and LOVT Scenarios

Extreme East-West (Horizontal) Aorta

How Many TAVR Systems Are Needed in a Busy TAVR Program?

Classification of Aortic Stenosis Based Upon the Extent of Cardiac Damage A Novel Concept

Valve, Heal Thyself: Pioneers Seek Tissue-Engineered Fix for Faulty, Failing Cardiac Parts

A Prospective, Randomised Investigation of a Novel Transcatheter Aortic Valve Implantation System: The REPRISE III Trial

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

Permanent Pacemakers After TAVR: Model Helps Predict Individual Patient Risk With Sapien 3

Live From Washington: ACC 2017, Day One

SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients

Novel Applications: Utilizing Impella to Support TAVR Patients

Edward ‘Ted’ Diethrich, Founder of the Arizona Heart Institute, Dies at 81

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content